DC
NUVB icon

Decheng Capital’s Nuvation Bio NUVB Stock Holding History

Decheng Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147M Hold
25,954,439
– – 20.15% 2
2026
Q1 		$111M Hold
25,954,439
– – 16.84% 2
2025
Q4 		$233M Hold
25,954,439
– – 31.28% 2
2025
Q3 		$96M Hold
25,954,439
– – 16.75% 2
2025
Q2 		$50.6M Hold
25,954,439
– – 12.78% 3
2025
Q1 		$45.7M Hold
25,954,439
– – 12.81% 2
2024
Q4 		$69M Hold
25,954,439
– – 14.81% 2
2024
Q3 		$59.4M Buy
25,954,439
+19,004,200
+273% +$58M 14.08% 2
2024
Q2 		$20.3M Buy
+6,950,239
New +$21.2M 6.22% 2

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Decheng Capital's NUVB Position: Q2 2026 in Review

Decheng Capital held its Nuvation Bio (NUVB) position steady in Q2 2026 at 25,954,439 shares worth $147M. The position accounts for 20.15% of the portfolio, ranked #2.

Decheng Capital first reported a position in NUVB in Q2 2024 and has held it in 9 quarters since. The position peaked at $233M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Decheng Capital held 25,954,439 shares of Nuvation Bio worth $147M as of Q2 2026.
  • Decheng Capital left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up 20.15% of Decheng Capital's portfolio in Q2 2026, its #2 holding.
  • Decheng Capital first reported a position in Nuvation Bio in Q2 2024 and has held it in 9 quarters since.
  • Decheng Capital's Nuvation Bio position peaked at $233M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Decheng Capital's 13F filing for Q2 2026, filed 14 Aug 2026.